Biotech Analysis Central Pharma News: Johnson & Johnson's Partnership, Dynavax's Advancements, Aveo's Positive Results [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
Summary Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Johnson & Johnson Acquires Rights To A Drug That Treats Rare Forms Of Cancer News: Recently, Johnson & Johnson ( JNJ ) announced that it had created a partnership deal with a Korean biotech named Yuhan ( OTCPK:YUHNF ) . The reason for creating this deal is so that JNJ could get its hands on Yuhan's 3rd generation EGFR tyrosine-kinase inhibitor known as lazertinib. In order to obtain such a deal, JNJ only had to pay an upfront payment of $50 million to Yuhan. If clinical trials proceed accordingly, then Yuhan could also receive up to $1.205 billion in potential milestone payments as well. JNJ will also have to give the biotech tiered double-digit royalty payments for net sales made on any products sold. Analysis: I think this is a good deal for JNJ for a few reasons. The first reason is that it gets to work on the dru
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert [Yahoo! Finance]Yahoo! Finance
- Analyst updates Johnson & Johnson stock price target after earnings [Yahoo! Finance]Yahoo! Finance
- A creator made 5 figures with a dating podcast and quit her job to focus on her side hustle full-time. She breaks down her income from brand deals, sponsored events, and more. [Business Insider]Business Insider
- Two Nachawati Law Group Partners Listed Among Best Lawyers in Dallas by D Magazine [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website